Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours-Reference-Cited by-同舟云学术

Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours

Published:2015-03 Issue:7 Volume:112 Page:1199-1205
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Zurita A J,Khajavi M,Wu H-K,Tye L,Huang X,Kulke M H,Lenz H-J,Meropol N J,Carley W,DePrimo S E,Lin E,Wang X,Harmon C S,Heymach J V

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc201573.pdf

Reference37 articles.

1. Abdel-Rahman O (2014) Vascular endothelial growth factor (VEGF) pathway and neuroendocrine neoplasms (NENs): prognostic and therapeutic considerations. Tumour Biol 35 (11): 10615–10625.

2. Alitalo A, Detmar M (2012) Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene 31 (42): 4499–4508.

3. Arvidsson Y, Bergstrom A, Arvidsson L, Kristiansson E, Ahlman H, Nilsson O (2010) Hypoxia stimulates CXCR4 signalling in ileal carcinoids. Endocr Relat Cancer 17 (2): 303–316.

4. Auernhammer CJ, Goke B (2011) Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin. Gut 60 (7): 1009–1021.

5. Bergers G, Hanahan D (2008) Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8 (8): 592–603.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A neuroendocrine biomarker revolution from monoanalyte to multianalyte biomarkers in non-functioning gastro-entero-pancreatic neuroendocrine neoplasms;Critical Reviews in Oncology/Hematology;2024-11

2. Angiogenic biomarkers of response to treatment with peptide receptor radionuclide therapy in neuroendocrine tumours;Endokrynologia Polska;2024-07-24

3. Biochemical Markers for Neuroendocrine Tumors: Traditional Circulating Markers and Recent Development—A Comprehensive Review;Diagnostics;2024-06-18

4. Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues;Biomedicines;2023-03-10

5. Special issue “The advance of solid tumor research in China”: Prediction of Sunitinib efficacy using computed tomography in patients with pancreatic neuroendocrine tumors;International Journal of Cancer;2022-10-07